Nabla Bio Advances Generative Protein Design with $26M Series A Funding
Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportNabla Bio Advances Generative Protein Design with $26M Series A Funding